Amicus Therapeutics, Inc. (NASDAQ:FOLD) is a United States-based biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for treating a range of diseases, including lysosomal storage diseases and diseases of neurodegeneration. Amicus Therapeutics, Inc. (NASDAQ:FOLD) stock opened at $2.80 in last session, and closed at $2.72, while the day range of stock is $2.70 – $ 2.98. The stock showed a positive weekly performance of 4.62%.
Sanofi SA (ADR) (NYSE:SNY), the healthcare provider based in France, reported fourth quarter profits in line with the projections. Although sales were lower on the back of the weaker currency scenario in the emerging markets. Sanofi SA (ADR) (NYSE:SNY) stock opened at $49.23, in last session and closed at $49.16, by losing -0.57%. The 52 week range of the stock is $46.16 – $55.94. Company’s market capitalization is $130.97 billion.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has selected a new drug development candidate, BMN 250, a novel fusion of alpha-N-acetyglucosaminidase (NAGLU) with a peptide derived from insulin-like growth factor 2 (IGF2), for the treatment of Sanfilippo B syndrome or Mucopolysaccharidosis type IIIB (MPS IIIB). BioMarin has initiated IND-enabling studies and expects to initiate clinical studies with BMN 250 in mid-2015. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stock advanced 3.08% and finished the last session at $73.01. The EPS of the stock remained -1.27. Company’s market capitalization is $10.38 billion.
Zacks lowered shares of Novo Nordisk (NYSE:NVO) from an outperform rating to a neutral rating in a report released on Monday, AnalystRatingsNetwork.com reports. Novo Nordisk A/S (ADR) (NYSE:NVO) stock opened the session at $42.38, and closed the session at $42.88. The 52 week range of the stock remained $29.90 – $43.02 and the day range was $42.38 -$43.02.
Leave a Reply